SECTION MENU

Mayo Clinic Reaches COVID-19 Therapy Milestone

January 04, 2022

Mayo Clinic Reaches COVID-19 Therapy Milestone

Mayo Clinic has one of the most robust monoclonal antibody therapy programs in the country, and the program has strongly contributed to the state of Minnesota’s public health and ability to confront the COVID-19 pandemic.

Mid-December marked a milestone, as Mayo Clinic Health System infused its 10,000th patient with monoclonal antibodies. To date, 20,000 infusions have been performed across all Mayo Clinic locations including Arizona and Florida. Monoclonal antibodies are drugs that consist of one (mono-) neutralizing antibody copied (cloned) in a lab that helps to decrease the amount of virus circulating in the body. Earlier in 2021, Mayo Clinic researchers concluded that, based on real-world data, monoclonal antibodies help patients avoid hospitalization when administered early on before the disease progresses. Additional Mayo Clinic research has shown up to 70% reduction in hospitalization.
   —Please visit https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-health-system-reaches-covid-19-therapy-milestone/ for more information.